(C6D6): d 7.52 (dd, J 1.2, 7.5 Hz, 2H), 7.25 (t, J 7.6 Hz, 12H), 7.11 (t, J 7.5
Hz, 2H), 7.06–7.00 (m, 20H), 3.27 (sept, J 6.5 Hz, 4H), 2.53 (s, 12H), 1.08
(d, J 6.5 Hz, 12H), 0.93 (d, J 6.5 Hz, 12H). 13C{1H} NMR (C6D6): d 175.9,
152.1, 143.8, 129.9, 128.5, 128.3, 126.8, 124.7, 123.7, 123.2, 121.8, 116.6,
77.2, 50.9, 25.3, 24.2. For (Pri4Xan)Zr2Bn6: 1H NMR (C6D6): d 7.18 (t, J 7.7
Hz, 12H), 7.04 (dd, J 1.6, 7.8 Hz, 2H), 7.00 (d, J 7.3 Hz, 12H), 6.97 (t, J 7.4
Hz, 6H), 6.92 (t, 7.5 Hz, 2H), 6.71 (dd, J 1.6, 7.3 Hz, 2H), 3.36 (sept, J 6.6
Hz, 4H), 2.65 (s, 12H), 1.35 (s, 6H), 1.31 (d, J 6.5 Hz, 12H), 0.91 (d, J 6.7
Hz, 12H); 13C{1H} NMR (C6D6): d 177.1, 146.2, 144.3, 130.2, 129.7,
128.6, 128.3, 128.1, 127.9, 127.5, 123.7, 123.0, 120.5, 78.2, 51.0, 34.2,
33.4, 26.4, 24.2. For (Pri4Xan)ZrBn2: 1H NMR (C6D6): d 7.61 (d, J 7.6 Hz,
4H), 7.42 (t, J 7.6 Hz, 4H), 7.08 (t, J 7.3 Hz, 2H), 7.05 (dd, J 1.4 Hz, 7.3 Hz,
2H), 6.93 (dd, J 1.4, 7.9 Hz, 2H), 6.74 (t, J 7.6 Hz, 2H), 3.54 (sept, J 6.5 Hz,
4H), 2.92 (s, 4H), 1.27 (s, 6H), 1.12 (d, J 6.5 Hz, 12H), 0.84 (d, J 6.3 Hz,
12H); 13C{1H} NMR (C6D6): d 165.2, 148.5, 144.5, 129.1, 128.5, 128.3,
127.9, 126.7, 126.5, 125.1, 123.0, 121.6, 75.2, 50.8, 34.2, 32.5, 25.6,
25.1.
‡ Crystal data for (Pri4DBF)Zr2(CH2Ph)6·1.5Et2O: C74H91N4O2.5Zr2, M =
¯
1258.95, triclinic, space group P1 (no. 2), a = 11.392(2), b = 18.274(4), c
Fig. 2 Molecular structure of (Pri4Xan)Zr2(CH2Ph)6·Et2O drawn with 50%
thermal ellipsoids. Cocrystallized ether is omitted. Selected distances (Å)
and angles (°): Zr1–Nav 2.24, Zr1–Cav (excl. C31) 2.28, Zr1–C31 2.627(3),
Zr2–Nav 2.24, Zr2–Cav (excl. C52) 2.28, Zr2–C52 2.678(4), Zr1–Zr2
6.489(1); Zr1–C30–C31 86.2(2), Zr2–C51–C52 89.8(2).
= 18.717(4) Å, a = 109.66(3), b = 102.65(3), g = 105.50(3)°, V =
3324.7(12) Å3, Z = 2, m = 0.34 mm21, T = 2138 °C, 20243 independent
reflections, Rint = 0.0482, 11705 observations, 783 parameters, R1
=
0.0603, wR2 = 0.1571, GOF = 0.973. For (Pri4Xan)Zr2(CH2Ph)6·Et2O:
75H92N4O2Zr2, M = 1263.97, monoclinic, space group P21/n (no. 14), a
C
= 17.940(4), b = 18.075(4), c = 21.577(4) Å, b = 105.70(3)°, V =
6736(2) Å3, Z = 4, m = 0.36 mm21, T = 2138 °C, 21557 independent
reflections, Rint = 0.1058, 10074 observations, 752 parameters, R1
0.0637, wR2
=
= 0.1561, GOF =
0.929. For (Pri4Xan)Zr(CH2Ph)2:
C43H54N4OZr, M = 734.12, monoclinic, space group P21/c (no. 14), a =
10.887(2), b = 16.325(3), c = 21.427(4) Å, b = 96.47(3)°, V = 3784.1(13)
Å3, Z = 2, m = 0.33 mm21, T = 2138 °C, 12039 independent reflections,
Rint = 0.0554, 8425 observations, 452 parameters, R1 = 0.0455, wR2
=
0.1176, GOF = 1.008. Refinements were performed (SHELXTL-Plus
V5.0) on F2.
suppdata/cc/b1/b106972a/ for crystallographic data in CIF or other
electronic format.
1 For selected reviews, see: F. Fache, E. Schulz, M. L. Tommasino and M.
Lemaire, Chem. Rev., 2000, 100, 2159; A. Togni and L. M. Vananzi,
Angew. Chem., Int. Ed. Engl., 1994, 33, 497; M. J. Bartos, S. W. Gordon-
Wylie, B. G. Fox, L. J. Wright, S. T. Weintraub, K. E. Kauffmann, E.
Münck, K. L. Kostka, E. S. Uffelman, C. E. F. Rickard, K. R. Noon and
T. J. Collins, Coord. Chem. Rev., 1998, 174, 361; G. J. P. Britovsek, V.
C. Gibson and D. F. Wass, Angew. Chem., Int. Ed., 1999, 38, 428.
2 For metalloenzymes, see: F. A. Cotton and G. Wilkinson, Advanced
Inorganic Chemistry, Wiley Interscience, New York, 1988, 5th edn., ch.
30.
3 For selected synthetic examples and reviews, see: G. J. Rowlands,
Tetrahedron, 2001, 57, 1865; N. Wheatley and P. Kalck, Chem. Rev.,
1999, 99, 3379; Catalysis by Di- and Polynuclear Metal Cluster
Complexes, ed. R. D. Adams and F. A. Cotton, Wiley-VCH, Inc., New
York, 1998; R. G. Konsler, J. Karl and E. N. Jacobsen, J. Am. Chem. Soc.,
1998, 120, 10780; T. Ooi, M. Takahashi and K. Maruoka, Angew. Chem.,
Int. Ed., 1998, 37, 835; J. D. Wuest, Acc. Chem. Res., 1999, 32, 81; A.
Cottone III and M. J. Scott, Organometallics, 2000, 19, 5254; M. E.
Broussard, B. Juma, S. G. Train, W.-J. Peng, S. A. Laneman and G. G.
Stanley, Science, 1993, 260, 1784.
4 For other binucleating amidinates, see: J. R. Babcock, C. Incarvito, A. L.
Rheingold, J. C. Fettinger and L. R. Sita, Organometallics, 1999, 18,
5729; S. Appel, F. Weller and K. Dehnicke, Z. Anorg. Allg. Chem., 1990,
583, 7; C. Chen, L. H. Rees, A. R. Cowley and M. L. H. Green, J. Chem.
Soc., Dalton Trans., 2001, 1761; M. Ruben, D. Walther, R. Knake, H.
Görls and R. Beckert, Eur. J. Inorg. Chem., 2000, 5, 1055.
5 For related bis(phosphine) and bis(porphyrin) ligands, see: C. J. Chang,
Y. Q. Deng, A. F. Heyduk, C. K. Chang and D. G. Nocera, Inorg. Chem.,
2000, 39, 959; M. W. Haenel, D. Jakubik, E. Rothenberger and G.
Schroth, Chem. Ber., 1991, 124, 1705.
Fig. 3 Views of the molecular structure of (Pri4Xan)Zr(CH2Ph)2 drawn with
50% thermal ellipsoids. Pri groups omitted in (b) for clarity. Selected
distances (Å) and angles (°): Zr1–N1 2.269(2), Zr1–N2 2.247(2), Zr1–N3
2.288(2), Zr1–N4 2.308(2), Zr1–C30 2.280(2), Zr1–C37 2.284(2); C30–
Zr1–C37 88.87(8).
1
empirical formula [(Pri4Xan)Zr(CH2Ph)2]n. H NMR spectra
(C6D6) were also consistent with this formulation and featured
a single set of resonances for the benzyl ligands. Single crystal
X-ray diffraction studies revealed the product to be mono-
nuclear, with a single Zr atom bridging the two amidinates of
the (Pri4Xan) ligand (Fig. 3). Geometry at the Zr center closely
resembles that observed for Group 4 dialkyl derivatives of N4-
macrocycles.8 Interestingly, there appears to be significant ring
strain as a result of this binding mode. As shown in Fig. 3(b), the
amidinates are bent towards Zr giving angles of 114.1(2) and
115.2(2)° for C7–C8–C13 and C23–C21–C17, respectively.
Additionally, the Zr atom is coordinated ca. 1.2 Å out of each
NCN amidinate plane, and the Zr–N bond lengths suggest
stronger coordination to one of the amidinates. Asymmetric
binding, however, is not observed by 1H NMR spectroscopy (in
C6D6), and it is unclear whether this is due to fluxionality or a
lack of asymmetry.
6 D. Wood, G. P. A. Yap and D. S. Richeson, Inorg. Chem., 1999, 38,
5788.
We thank Professor Clark R. Landis for helpful discussions
and the University of Colorado for funding.
7 B. Qian, W. J. Scanlon, M. R. Smith and D. H. Morty, Organometallics,
1999, 18, 1693; R. F. Jordan, R. E. Lapointe, C. S. Bajgur, S. F. Echols
and R. Willett, J. Am. Chem. Soc., 1987, 109, 4111; S. L. Latesky, A. K.
McMullen, G. P. Niccolai, I. P. Rothwell and J. C. Huffman,
Organometallics, 1985, 4, 902.
Notes and references
† All compounds analyzed satisfactorily. Selected data for (Pri4DBF)H2: 1H
NMR (d6-acetone): d 8.12 (d, J 7.7 Hz, 2H), 7.42 (t, J 7.5 Hz, 2H), 7.33 (d,
J 7.3 Hz, 2H), 4.20 (br, 2H), 3.10 (br, 2H), 2.86 (br, 2H), 1.22 (br, 12H),
0.98 (br, 12H). For (Pri4Xan)H2: 1H NMR (d6-acetone): d 7.53 (d, J 7.7 Hz,
2H), 7.11 (t, J 7.5 Hz, 2H), 6.94 (d, J 7.1 Hz, 2H), 4.13 (br, 2H), 2.85 (m,
br, 4H), 1.63 (s, 6H), 1.36–0.80 (br, 24H). For (Pri4DBF)Zr2Bn6: 1H NMR
8 D. G. Black, D. C. Swenson, R. F. Jordan and R. D. Rogers,
Organometallics, 1995, 14, 3539; M. J. Scott and S. J. Lippard, Inorg.
Chim. Acta, 1997, 263, 287; H. Brand and J. Arnold, Coord. Chem. Rev.,
1995, 140, 137; L. Giannini, E. Solari, S. De Angelis, T. R. Ward, C.
Floriani, A. Chiesi-Villa and C. Rizzoli, J. Am. Chem. Soc., 1995, 117,
5801.
Chem. Commun., 2001, 2144–2145
2145